• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

下颌骨骨坏死相关性双膦酸盐相关性上颌窦炎和口鼻瘘的发生率。

Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.

机构信息

Department of Oral and Maxillofacial Surgery, University of Munich, Munich 80337, Germany.

出版信息

J Craniomaxillofac Surg. 2012 Oct;40(7):568-71. doi: 10.1016/j.jcms.2011.10.012. Epub 2011 Nov 26.

DOI:10.1016/j.jcms.2011.10.012
PMID:22118926
Abstract

OBJECTIVE

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious side-effect of bisphosphonate therapy. In the majority of cases BRONJ occurs in the mandible. As a consequence a detailed investigation of BRONJ of the maxilla and in particular of involvement of the maxillary sinus has largely so far been neglected. The aim of this study was to analyse the frequency of maxillary sinusitis and oro-antral fistulae in BRONJ of the maxilla.

SUBJECTS AND METHODS

A retrospective multicentre analysis was carried out in three Departments of Oral and Maxillofacial Surgery focussing on patients suffering from BRONJ in the maxilla. The role of involvement of the maxillary sinus, in particular sinusitis and oro-antral fistula, was analysed.

RESULTS

Out of a total of 170 patients suffering from BRONJ 53 cases (31.2%) with involvement of the maxilla were identified. At least one sign of maxillary sinusitis was present in 43.6% (23/53) and an oro-antral fistula in the course of the disease was detected in 35.8% (19/53) of those patients. The mean length of time of bisphosphonate intake was 36.16±16.32 months. Zoledronate was most frequently associated (60.4%) with symptoms, followed by the combination of Zoledronate/Ibandronate (13.2%), and Zoledronate/Pamidronate or Pamidronate alone (both 7.5%).

CONCLUSION

Maxillary sinusitis and oro-antral fistulae are associated with a BRONJ manifestation in the upper jaw in approximately 44%. The involvement of the maxillary sinus should be given special attention and three-dimensional imaging modalities might be necessary, not only to evaluate the extent of necrosis, but also to exclude involvement of the maxillary sinus.

摘要

目的

双膦酸盐相关性下颌骨坏死(BRONJ)是双膦酸盐治疗的严重副作用。在大多数情况下,BRONJ 发生在下颌骨。因此,上颌骨 BRONJ 的详细研究,特别是上颌窦的受累,在很大程度上迄今被忽视。本研究旨在分析上颌骨 BRONJ 中上颌窦炎和口鼻瘘的频率。

对象和方法

对三个口腔颌面外科系进行回顾性多中心分析,重点关注上颌骨 BRONJ 患者。分析了上颌窦受累的作用,特别是鼻窦炎和口鼻瘘。

结果

在总共 170 例 BRONJ 患者中,发现 53 例(31.2%)上颌骨受累。在 43.6%(23/53)的患者中存在至少一个上颌窦炎的征象,在 35.8%(19/53)的患者中在病程中检测到口鼻瘘。双膦酸盐摄入的平均时间为 36.16±16.32 个月。唑来膦酸最常与症状相关(60.4%),其次是唑来膦酸/伊班膦酸盐(13.2%),以及唑来膦酸/帕米膦酸盐或帕米膦酸盐单独使用(均为 7.5%)。

结论

上颌窦炎和口鼻瘘与上颌骨 BRONJ 表现相关,约占 44%。上颌窦受累应给予特别关注,可能需要三维成像方式,不仅要评估坏死的程度,还要排除上颌窦的受累。

相似文献

1
Incidence of maxillary sinusitis and oro-antral fistulae in bisphosphonate-related osteonecrosis of the jaw.下颌骨骨坏死相关性双膦酸盐相关性上颌窦炎和口鼻瘘的发生率。
J Craniomaxillofac Surg. 2012 Oct;40(7):568-71. doi: 10.1016/j.jcms.2011.10.012. Epub 2011 Nov 26.
2
Bisphosphonate-related osteonecrosis of the maxilla and sinusitis maxillaris.上颌骨和上颌窦骨坏死与双膦酸盐相关。
Int J Oral Maxillofac Surg. 2011 Mar;40(3):285-91. doi: 10.1016/j.ijom.2010.11.006. Epub 2010 Dec 15.
3
Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies.考虑原发性疾病和伴随治疗时双膦酸盐相关性颌骨骨坏死的发生率。
Anticancer Res. 2013 Sep;33(9):3917-24.
4
Involvement of the maxillary sinus in bisphosphonate-related osteonecrosis of the jaw: Radiologic aspects.上颌窦在双膦酸盐相关颌骨骨坏死中的累及情况:放射学表现
Am J Rhinol Allergy. 2017 Jan 1;31(1):36-39. doi: 10.2500/ajra.2017.31.4395.
5
[Review of bisphosphonate related osteonecrosis of the jaws].[双膦酸盐相关颌骨坏死的综述]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016 Apr 5;30(7):589-592. doi: 10.13201/j.issn.1001-1781.2016.07.026.
6
Sinusitis and oroantral fistula in patients with bisphosphonate-associated necrosis of the maxilla.双膦酸盐相关上颌骨坏死患者的鼻窦炎和口腔上颌窦瘘
Head Face Med. 2016 Jan 6;12:3. doi: 10.1186/s13005-015-0099-0.
7
Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.静脉注射双膦酸盐相关颌骨坏死:骨闪烁显像作为早期指标
J Oral Maxillofac Surg. 2009 Jul;67(7):1363-72. doi: 10.1016/j.joms.2009.03.005.
8
Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.双膦酸盐相关骨坏死:临床医生患者管理参考
Todays FDA. 2008 Aug;20(8):38-41, 43-6.
9
The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.手术切除在双膦酸盐相关颌骨骨坏死治疗中的作用。
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):85-95. doi: 10.1016/j.joms.2009.01.006.
10
CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.抗吸收剂相关性颌骨坏死/药物相关性颌骨坏死的 CT 影像学特征。
Dentomaxillofac Radiol. 2018 May;47(4):20170323. doi: 10.1259/dmfr.20170323. Epub 2018 Feb 13.

引用本文的文献

1
Fibula flap reconstruction for maxillary stage 3 medication-related osteonecrosis of the jaw from recipient and donor site perspectives: a preliminary single-center study.从受区和供区角度看腓骨瓣重建上颌骨3期药物相关性颌骨坏死:一项初步单中心研究
BMC Oral Health. 2024 Dec 26;24(1):1553. doi: 10.1186/s12903-024-05306-2.
2
Maxillary Sinusitis Induced by Medication-Related Osteonecrosis of the Jaw.药物相关性颌骨坏死所致上颌窦炎
Cureus. 2023 Sep 1;15(9):e44537. doi: 10.7759/cureus.44537. eCollection 2023 Sep.
3
Retrospective Analysis of Treatment Outcomes of Maxillary Sinusitis Associated with Medication-Related Osteonecrosis of the Jaw.
药物相关性颌骨坏死伴发上颌窦炎治疗效果的回顾性分析。
Int J Environ Res Public Health. 2022 Jun 17;19(12):7430. doi: 10.3390/ijerph19127430.
4
Surgical treatment of 61 consecutive patients with maxillary stage 3 medication-related osteonecrosis of the jaws using a pedicled buccal fat pad.采用带蒂颊脂垫外科治疗 61 例上颌骨 3 期药物相关性颌骨骨坏死患者。
Oral Maxillofac Surg. 2023 Jun;27(2):251-261. doi: 10.1007/s10006-022-01061-2. Epub 2022 Apr 1.
5
Medication-related osteonecrosis of the jaw: Prosthodontic considerations.药物相关性颌骨坏死:口腔修复学考量
Jpn Dent Sci Rev. 2022 Nov;58:9-12. doi: 10.1016/j.jdsr.2021.11.005. Epub 2021 Dec 18.
6
Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).感染是导致药物相关性颌骨坏死(MRONJ)的一个重要因素。
Medicina (Kaunas). 2021 May 9;57(5):463. doi: 10.3390/medicina57050463.
7
Management of Large Oroantral Fistulas Caused by Medication-Related Osteonecrosis with the Combined Sequestrectomy, Buccal Fat Pad Flap and Platelet-Rich Fibrin.采用死骨切除术、颊脂垫瓣和富血小板纤维蛋白联合治疗药物相关性骨坏死所致的大型口腔上颌窦瘘
J Maxillofac Oral Surg. 2021 Mar;20(1):76-82. doi: 10.1007/s12663-019-01278-x. Epub 2019 Aug 30.
8
Treatment of bisphosphonate-related osteonecrosis of the jaws - a report of seven cases.双膦酸盐相关颌骨骨坏死的治疗——7例报告
Contemp Oncol (Pozn). 2016;20(6):486-490. doi: 10.5114/wo.2016.65610. Epub 2017 Jan 12.
9
Treatment of stage II medication-related osteonecrosis of the jaw with necrosectomy and autologous bone marrow mesenchymal stem cells.采用坏死骨切除术和自体骨髓间充质干细胞治疗II期药物相关性颌骨坏死。
Odontology. 2017 Oct;105(4):484-493. doi: 10.1007/s10266-017-0295-4. Epub 2017 Feb 20.
10
Sinusitis and oroantral fistula in patients with bisphosphonate-associated necrosis of the maxilla.双膦酸盐相关上颌骨坏死患者的鼻窦炎和口腔上颌窦瘘
Head Face Med. 2016 Jan 6;12:3. doi: 10.1186/s13005-015-0099-0.